PYPD

Polypid Ltd.

• TipRanks·06/01 15:10

  Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), IN8bio (INAB) and PolyPid (PYPD)

• TipRanks·06/01 14:27

  PolyPid completes NDA submission to FDA for D-PLEX100

• TipRanks·06/01 13:14

  PolyPid Files NDA with FDA for Lead Infection-Prevention Drug D-PLEX100

• Benzinga·06/01 12:40

  PolyPid Completes Its New Drug Application Submission On Rolling Review Basis Top FDA For D-PLEX100 To Prevent Surgical Site Infections

• PUBT·06/01 12:32

  PolyPid submits D-PLEX100 NDA to FDA under rolling review

• Reuters·06/01 12:30

  POLYPID - FDA DECISION ON D-PLEX100 EXPECTED IN Q1 2027 UNDER PDUFA TIMELINE

• PUBT·05/20 12:32

  PolyPid management attends Craig-Hallum institutional investor conference investor meetings

• TipRanks·05/20 07:59

  PolyPid’s Earnings Call Signals Tightrope to Approval

• TipRanks·05/14 15:00

  Analysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Aptevo Therapeutics (APVO)

• TipRanks·05/14 10:31

  PolyPid (PYPD) Receives a Buy from H.C. Wainwright

• TipRanks·05/14 00:30

  PolyPid Earnings Call: NDA Momentum Amid Cash Strain

• TipRanks·05/13 17:09

  PolyPid reports Q1 EPS (35c), consensus (43c)

• Benzinga·05/13 13:24

  PolyPid Q1 2026 Earnings Call: Complete Transcript

• TipRanks·05/13 11:58

  PolyPid Advances D-PLEX₁₀₀ Toward FDA Review as Q1 2026 Loss Narrows and Debt Is Retired

• PUBT·05/13 11:31

  PolyPid Q1 FY26 net loss narrows 7.61% to $7.7 million